Tumor Biology

该期刊要求在投稿过程中列出每位作者的贡献,并在提交稿件中于致谢部分之后加入“作者贡献”标题,该信息将在校对阶段显示在作者贡献标题下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊致力于促进研究的开放性、透明度和可重复性,鼓励作者在相关公共数据存储库中共享研究数据,并包含链接到数据的数据可用性声明;如无法共享数据,应在声明中确认原因,并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊要求作者在指定标题下包含伦理批准声明,即使已在方法部分包含伦理批准信息;若无需伦理批准,需明确说明。所有涉及人类参与者、人类数据或人体组织的研究论文必须声明相关伦理委员会或机构审查委员会批准了该研究或豁免了批准要求,并提供审查委员会的全名、机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

《Tumor Biology》是一本开放获取、同行评审的期刊,所有被接受的文章在发表后立即免费在线提供,采用知识共享许可协议发布并永久在线托管;稿件经同行评审被接受后需支付一次性文章处理费(APC),由资助者、机构或作者支付,提交稿件不收费。原创文章、综述文章、研究方案和方法文章的APC为2100美元。 模型中文摘要

Tumor Biology is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, ins…

该期刊采用单盲同行评审流程,审稿人与编辑互动,不公布审稿信息;稿件将进行初步评估,若不符合指南要求将被退回修改,若超出期刊范围或不合适可能在同行评审前被直接拒稿,通过初步评估后将进行同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

该期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的问题,建议阅读Sage关于抄袭的完整政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊考虑已在预印本服务器上发布的稿件,投稿时需在指定字段输入预印本DOI,建议在投稿时告知期刊编辑部已发布的预印本,且在同行评审期间不应在预印本服务器上发布更新版本的稿件。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊认可ICMJE要求,即临床试验在或之前首次招募参与者时在WHO批准的公共试验注册处注册;但根据AllTrials运动,若延迟注册的理由可接受,将考虑回顾性注册的试验;试验注册名称、URL和注册号必须包含在摘要末尾。 模型中文摘要

The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …